Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | XGN Exagen Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $7.89 -3.0% | $15.90 -2.5% |
| StockIQ Score | 51C- Moderate Risk: Medium | 41D Weak Risk: High |
| Technical | 60C+ | 36F |
| Fundamental | 35F | 35F |
| Growth | 37F | 50C- |
| Fair Value | 38F | 38F |
| News | 100A+ | 50C- |
| Quality | 58C | 50C- |
| Risk | 48D+ | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Exagen (XGN) outperforms Ascentage Pharma (AAPG) in technicals (60 vs. 36) and investor sentiment (51 vs. 41), while AAPG leads slightly in growth (50 vs. 37). Both share equal fundamental and valuation scores (35 and 38 respectively), but XGN’s moderate rating contrasts with AAPG’s weak one. XGN shows stronger overall stability and market confidence.
